55 min
Episode 55: The Story of Radiology AI with Dr. Hugh Harvey �� The Healthtech Podcast
-
- Entrepreneurship
How do you build an AI company in healthcare? What can AI in radiology actually do? What should it be doing? Are clinicians ever going to be replaced? What does the future look like in healthcare AI?
This week, James is joined by Dr. Hugh Harvey, who was a consultant radiologist before entering academia and completing an MD research degree in computational analysis of prostate MR, and winning science writer of the year twice in a row.
Hugh worked as a consultant radiologist in the NHS (Guy’s and St. Thomas’ NHS Trust), and sat on the Royal College of Radiologists committee for medical imaging informatics as well as the AI working group. He now acts as a consultant and advisory board member for AI start-ups in the UK, EU and America within the imaging and healthcare space, as well as sitting on several AI and academic committees including the KSS Academic Health Science Network AI Core Advisory Group. He has co-authored several white papers and reports on AI in healthcare, alongside bodies such as Reform, an independent think-tank, and Health Education England and is an associate editor at Nature: Digital Medicine.
He acted as co-chair of the Topol Review, a seminal independent report for the UK Secretary of State for Health into preparing the healthcare workforce to deliver the digital future - read my take on the Topol Review for Forbes here: https://www.forbes.com/sites/jamessomauroo/2019/02/11/nhs-announces-workforce-plan-for-genomics-ai-and-digital-medicine/
And Hugh has deep start-up experience both as the lead for regulatory affairs at Babylon (recently valued >$1B) and then the Clinical Director at Kheiron Medical ($22M series A raise), where they developed deep learning software to improve breast cancer screening, and were the first UK company to receive the CE mark for a deep learning application in radiology.
Hugh's unique career enables dynamic bridging between the medical, technical and business worlds, with academic, clinical and operational expertise in cognitive digital solutions. He’s a pragmatist, a realist and incredibly refreshing and entertaining on social media
@DrHughHarvey | hugh@hardianhealth.com
For more information and content, check out our website www.hs.ventures. You can follow us on Twitter @HSVenture, on Instagram @hs.ventures, on Linkedin at HS. and you can email us at info@hs.live
You can get our host, Dr. James Somauroo, at www.jamessomauroo.com and you can follow him on Twitter @jamessomauroo, on Instagram @j_soms and on Linkedin at james-somauroo
How do you build an AI company in healthcare? What can AI in radiology actually do? What should it be doing? Are clinicians ever going to be replaced? What does the future look like in healthcare AI?
This week, James is joined by Dr. Hugh Harvey, who was a consultant radiologist before entering academia and completing an MD research degree in computational analysis of prostate MR, and winning science writer of the year twice in a row.
Hugh worked as a consultant radiologist in the NHS (Guy’s and St. Thomas’ NHS Trust), and sat on the Royal College of Radiologists committee for medical imaging informatics as well as the AI working group. He now acts as a consultant and advisory board member for AI start-ups in the UK, EU and America within the imaging and healthcare space, as well as sitting on several AI and academic committees including the KSS Academic Health Science Network AI Core Advisory Group. He has co-authored several white papers and reports on AI in healthcare, alongside bodies such as Reform, an independent think-tank, and Health Education England and is an associate editor at Nature: Digital Medicine.
He acted as co-chair of the Topol Review, a seminal independent report for the UK Secretary of State for Health into preparing the healthcare workforce to deliver the digital future - read my take on the Topol Review for Forbes here: https://www.forbes.com/sites/jamessomauroo/2019/02/11/nhs-announces-workforce-plan-for-genomics-ai-and-digital-medicine/
And Hugh has deep start-up experience both as the lead for regulatory affairs at Babylon (recently valued >$1B) and then the Clinical Director at Kheiron Medical ($22M series A raise), where they developed deep learning software to improve breast cancer screening, and were the first UK company to receive the CE mark for a deep learning application in radiology.
Hugh's unique career enables dynamic bridging between the medical, technical and business worlds, with academic, clinical and operational expertise in cognitive digital solutions. He’s a pragmatist, a realist and incredibly refreshing and entertaining on social media
@DrHughHarvey | hugh@hardianhealth.com
For more information and content, check out our website www.hs.ventures. You can follow us on Twitter @HSVenture, on Instagram @hs.ventures, on Linkedin at HS. and you can email us at info@hs.live
You can get our host, Dr. James Somauroo, at www.jamessomauroo.com and you can follow him on Twitter @jamessomauroo, on Instagram @j_soms and on Linkedin at james-somauroo
55 min